In order for health systems to "not be commoditized fully," they need to collect data to know their patients' behaviors better and build stronger relationships with them, argued Sara Vaezy, Providence's chief strategy and digital officer. Consumer brands like Amazon have been doing this for years so they can deliver personalized experiences to their users, and it's time hospitals take a page out of their playbook, she said.
If you haven't already - You still have time to provide us feedback on what works for you and what doesn't on MedCity News. Please take a few moments to share your thoughts. At the end of the survey, you can enter to win a $250 gift card. Thank you.
Providers, administrators, health insurers and other healthcare-access gatekeepers can learn, train, change policies and remove barriers facing vulnerable groups so they can receive the long-overdue opportunity to pursue their best health and well-being.
The next generation of senior living searchers are markedly different from their predecessors, and they will challenge us to work together to reshape their search experience.
San Diego-based Equip, which was founded in 2019, previously focused on those ages 6 to 24. The startup is now expanding to serve people of all ages, it announced Tuesday.
Standard newborn screening can detect dozens of inherited diseases, but genomics technology enables testing for hundreds of them. A North Carolina program evaluating the feasibility of bringing genomics to newborn screening is expanding with an initial goal of testing 5,000 babies in the next year.
In the inaugural episode of the MedCity FemFwd podcast, Michelle Long, senior policy analyst for the Women's Health Policy program at KFF, talks about Opill, which recently made headlines as the first daily oral contraceptive approved for nonprescription use in the U.S. Long tells listeners why this news is significant and examines whether the medication will be covered by insurance.
No comments